Visit the HL7 website
Visit the FHIR website

CA Core+ v1.1.0 DFT-preBallot

1.1.0-DFT-preBallot   Canada flag
  • Index
  • Home
  • Business Context
    • Business Context
    • Relationship to PCHDCF
    • Relationship to Other Specifications
    • CA Core+ to pCHDCF Mapping
  • Technical Context
    • Technical Context
    • Artifact Status Summary
    • Profiling Conventions & Approach
    • General Guidance
    • Mapping Logic
    • Security And Privacy
  • Modules
    • Modules
    • Common Data Exchange
    • Workflows
  • FHIR Artifacts
    • FHIR Artifacts
    • Profiles
    • Extensions
    • Data Types
    • Terminology
    • Examples
    • Download
  • Change Log
    • Change Log
    • Specification Guidance
    • Copyrights
    • Known Issues & Future Development
    • Specification Feedback
    1. Index
    2. FHIR Artifacts
    3. Examples
    4. Example MedicationStatement

DFT-preBallot - The specification is a DFT-preBallot version of CA Core+ for collecting community feedback. For a full list of available versions, see the Directory of published versions

Example MedicationStatement

  • Overview
  • XML
  • JSON
MedicationStatement
id : example-medicationstatement-ca-core
meta
profile : http://fhir.infoway-inforoute.ca/cacore/StructureDefinition/medicationstatement-ca-core
status : active
medication
reference : Medication/example-medication-ca-core
subject
reference : example-patient-ca-core-2
effective
start : 2024-03-27
end : 2024-12-31
reasonCode
coding
system : http://snomed.info/sct
code : 22298006
display : Myocardial infarction (disorder)
text : Secondary prevention of cardiovascular events
dosage
text : Take 20mg once daily at bedtime
route
coding
system : http://snomed.info/sct
code : 26643006
display : Oral route (qualifier value)
<MedicationStatement xmlns="http://hl7.org/fhir">
<id value="example-medicationstatement-ca-core" />
<meta>
<profile value="http://fhir.infoway-inforoute.ca/cacore/StructureDefinition/medicationstatement-ca-core" />
</meta>
<status value="active" />
<medicationReference>
<reference value="Medication/example-medication-ca-core" />
</medicationReference>
<subject>
<reference value="example-patient-ca-core-2" />
</subject>
<effectivePeriod>
<start value="2024-03-27" />
<end value="2024-12-31" />
</effectivePeriod>
<reasonCode>
<coding>
<system value="http://snomed.info/sct" />
<code value="22298006" />
<display value="Myocardial infarction (disorder)" />
</coding>
<text value="Secondary prevention of cardiovascular events" />
</reasonCode>
<dosage>
<text value="Take 20mg once daily at bedtime" />
<route>
<coding>
<system value="http://snomed.info/sct" />
<code value="26643006" />
<display value="Oral route (qualifier value)" />
</coding>
</route>
</dosage>
</MedicationStatement>
{
"resourceType": "MedicationStatement",
"id": "example-medicationstatement-ca-core",
"meta": {
"profile": [
"http://fhir.infoway-inforoute.ca/cacore/StructureDefinition/medicationstatement-ca-core"
]
},
"status": "active",
"medicationReference": {
"reference": "Medication/example-medication-ca-core"
},
"subject": {
"reference": "example-patient-ca-core-2"
},
"effectivePeriod": {
"start": "2024-03-27",
"end": "2024-12-31"
},
"reasonCode": [
{
"coding": [
{
"code": "22298006",
"system": "http://snomed.info/sct",
"display": "Myocardial infarction (disorder)"
}
],
"text": "Secondary prevention of cardiovascular events"
}
],
"dosage": [
{
"text": "Take 20mg once daily at bedtime",
"route": {
"coding": [
{
"code": "26643006",
"system": "http://snomed.info/sct",
"display": "Oral route (qualifier value)"
}
]
}
}
]
}

IG © based on FHIR R4 | Package package:ca.infoway.io.core@1.1.0-dft-preballot
HL7® and FHIR® are the registered trademarks of Health Level Seven International